Gaurav Shah - Feb 7, 2022 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role: CEO, Director
Signature: /s/ Martin Wilson, as attorney-in-fact for Gaurav Shah
Stock symbol: RCKT
Transactions as of: Feb 7, 2022
Transactions value $: $381,513
Form type: 4
Date filed: 2/8/2022, 03:43 PM
Next filing: Feb 16, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RCKT	Common Stock	Purchase	$382K	+22K	+4.44%	$17.34	518K	Feb 7, 2022	Direct	F1
holding	RCKT	Common Stock						208K	Feb 7, 2022	By Spouse
holding	RCKT	Common Stock						198K	Feb 7, 2022	By Gaurav D. Shah Irrevocable Trust

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.03 to $17.50, inclusive. The reporting person undertakes to provide to Rocket Pharmaceuticals, Inc. ("RCKT"), any security holder of RCKT, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.03 to $17.50, inclusive. The reporting person undertakes to provide to Rocket Pharmaceuticals, Inc. ("RCKT"), any security holder of RCKT, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.

Remarks:

Exhibit 24: Power of Attorney